© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY · WNPR
WPKT · WRLI-FM · WEDW-FM · Public Files Contact
ATSC 3.0 FAQ
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Company Seeks Approval For Experimental Ebola Drug

Published August 7, 2014 at 1:40 PM EDT

There is no known cure for the Ebola virus, but a number of labs have been working on one. The two American relief workers recently flown back from Liberia have been receiving an experimental treatment produced by a company in San Diego.

Another company, Cambridge, Mass.-based Sarepta Therapeutics, also has an experimental drug. The company’s CEO, Chris Garabedian, tells Here & Now’s Robin Young how this treatment would work, and what it takes to get the drug to patients.

Guest

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Robots weld the bodies of Porsche Macan SUVs at the new heavily automated Porsche Macan factory at the Porsche plant in February in Leipzig, Germany. (Sean Gallup/Getty Images)
/
Robots weld the bodies of Porsche Macan SUVs at the new heavily automated Porsche Macan factory at the Porsche plant in February in Leipzig, Germany. (Sean Gallup/Getty Images)

Stand up for civility

This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.

We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.

Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.

Donate